It may reflect the proinflammatory cytokine activity, in particular interleukin-6 (McKeown et al, 2004), which not only stimulates breast tumour growth (Kurebayashi, 2000), but also produce profound catabolic effects on host metabolism (McMillan et al, 1998; Kotler, 2000). This evidence concerns the gene IL6 and breast neoplasm.